Summary
Although several COVID-19 vaccines have now proven their worth and gained the authority of emergency use in several countries, they will be scarce for several months – even in rich countries, and especially for healthy people, to some extent. good young. In the rest of the world, waiting for these vaccines could last longer, into 2022, as richer countries have bought most of the original stores, which is sad for global health advocates. The COVID-19 Vaccines Global Access (COVAX) facility, set up by the World Health Organization and its partners to help purchase and circulate proven vaccines, was intended for eradication to such inequality. But COVAX is scarce for money and its effects are yet to be seen. And some countries around the world are not waiting for international help. In a free world for all, they are dealing with companies to secure their products and authorizing them for use even before the final efficiency results are in.